Is a complete LEXX research report available?

No complete published report is available for Lexaria Bioscience Corp. (LEXX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · USD

$0.40

-0.13 (-25.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LEXX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.8M
Revenue (ttm)	194K
Net income (ttm)	-7.7M
EPS (ttm)	-$0.34
Shares out	24.8M
Volume	733,302
Beta	0.34
Price target	$3.50	+783.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 194K
Net income (ttm): -7.7M
EPS (ttm): -$0.34
Market cap: 9.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LEXX indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001348362
Company name	Lexaria Bioscience Corp.
Country	Canada
Country code	US
Cusip	52886N406
Employees	7
Employees Change	2%
Employees Change Percent	40
Enterprise value	$6.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US52886N4060
Last refreshed	2026-07-31
Market cap	$9.8M
Market cap category	Nano-Cap
Price	$0.4
Price currency	USD
Rev Per Employee	27,714.29x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	LEXX
Website	https://lexariabioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-78.71%
EV/Sales	32.44x
FCF yield	-76.01%
P/B ratio	2.07x
P/S ratio	50.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3,973.16%
EBITDA Margin	-3,933.69%
Gross margin	100%
Gross Profit	$194,000
Gross Profit Growth	-68.36%
Gross Profit Growth3 Y	-6.04%
Gross Profit Growth5 Y	-20.1%
Net Income	$-7.7M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-3,987.65%
Profit Per Employee	$-1.1M
ROA	-81.3
Roa5y	-65.6
ROCE	-175.3
ROE	-162.8
Roe5y	-123.8
ROIC	-96.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-20.56%
Cagr15y	-17.49%
Cagr1y	-55.45%
Cagr3y	-21.19%
Cagr5y	-43.2%
EPS Growth Quarters	4
EPS Growth Years	0
Revenue Growth	-68.5x
Revenue Growth Years	2x
Revenue Growth3 Y	-14.15x
Revenue Growth5 Y	-23.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$4.8M
Cash	$3.6M
Current Assets	$4.1M
Current Liabilities	$383,412
Debt	$86,714
Debt Equity	$0.02
Equity	$4.3M
Liabilities	$437,091
Long Term Assets	$716,462
Long Term Liabilities	$53,679
Net Cash	$3.5M
Net Cash By Market Cap	$35.94
Net Cash Growth	-21.7%
Net Debt Equity	$-0.81
Tangible Book Value	$4.4M
Tangible Book Value Per Share	$0.18
WACC	6.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.6
Net Working Capital	$97,386
Quick ratio	9.56
Working Capital	$3.7M
Working Capital Turnover	$0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-32.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-89.99%
1Y total return	-55.43%
200-day SMA	0.77
3Y total return	-51.07%
50-day SMA	0.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.09%
All Time High	180
All Time High Change	-99.78%
All Time High Date	2007-10-10
All Time Low	0.22
All Time Low Change	81.62%
All Time Low Date	2012-11-21
ATR	0.06
Beta	0.34
Beta1y	0.98
Beta2y	0.71
Ch YTD	-35.77
High	0.55
High52	1.55
High52 Date	2025-09-25
High52ch	-74.43%
Low	0.37
Low52	0.37
Low52 Date	2026-07-30
Low52ch	6.36%
Ma50ch	-32.57%
Premarket Change Percent	1.68
Premarket Price	$0.54
Premarket Volume	103
Price vs 200-day SMA	-48.69%
RSI	30
RSI Monthly	35.58
RSI Weekly	36.54
Sharpe ratio	-0.22x
Sortino ratio	-0.24
Total Return	-32.4%
Tr YTD	-35.77
Tr15y	-94.41%
Tr1m	-30.31%
Tr1w	-30.5%
Tr3m	-42.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.06
Earnings Revenue Estimate	20,000x
Earnings Revenue Estimate Growth	-88.51x
Operating Income	$-7.5M
Operating margin	-3,862.9
Price target	$3.5
Price Target Change	$783

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,038,682%
Float Percent	96.98%
Shares Insiders	1.67%
Shares Institutions	6.09%
Shares Out	24,787,446
Shares Qo Q	1.48%
Shares Yo Y	32.4%
Short Float	0.68%
Short Ratio	2.66
Short Shares	0.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.8M
Adjusted OCF	-7,790,946
Average Volume	105,176.95x
Bv Per Share	0.19
CAPEX	$-40,817
Ch10y	-89.99
Ch15y	-94.41
Ch1m	-30.31
Ch1w	-30.5
Ch1y	-55.43
Ch3m	-42.47
Ch3y	-51.07
Ch5y	-94.09
Ch6m	-47.57
Change	-25.23%
Change From Open	-23.79
Close	0.53
Days Gap	-1.89
Depreciation Amortization	76,573
Dollar Volume	290,607.6
Earnings Date	2026-07-13
Earnings Time	amc
EBIT	$-7.7M
EBITDA	$-7.6M
EPS	$-0.34
F Score	3
FCF	$-7.5M
FCF EV Yield	-118.65x
FCF Per Share	$-0.3
Financing CF	6,518,105
Fiscal Year End	August
Founded	2,004
Income Tax	$4,403
Investing CF	-243,975
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-13
Last Report Date	2026-05-31
Last Split Date	2021-01-12
Last Split Type	Reverse
Last10k Filing Date	2025-11-28
Ma150	0.7
Ma150ch	-43.06%
Ma20	0.57
Ma20ch	-29.93%
Net CF	-1,116,758
Next Earnings Date	2026-11-27
Open	0.52
Optionable	No
Position In Range	13.36
Post Close	0.4
Postmarket Change Percent	3.79
Postmarket Price	$0.41
Ppne	313,432
Pre Close	0.53
Price Date	2026-07-30
Ptbv Ratio	2.23
Relative Volume	6.97x
Revenue	194,000x
SBC By Revenue	188.38x
Share Based Comp	365,458
Tax By Revenue	2.27x
Tr6m	-47.57%
Volume	733,302
Z Score	2.43

Lexaria Bioscience Corp. (LEXX)

Coverage state: Market snapshot only — no published research

Generate the first LEXX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LEXX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LEXX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LEXX

Frequently asked questions